summit study tirzepatide In pts wiht HFpEF and obesity, (Mounjaro®) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in trial https://t.co/8ZHm4gySiL SURMOUNT-1 Trial - Cardionerds Twitter
Pay in 4 interest-free payments of $5.53 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7




























